Literature DB >> 24416798

Confidence limits for prevalence of disease adjusted for estimated sensitivity and specificity.

Zsolt Lang, Jenő Reiczigel.   

Abstract

Prevalence of a disease is usually assessed by diagnostic tests that may produce false results. Rogan and Gladen (1978) described a method to estimate the true prevalence correcting for sensitivity and specificity of the diagnostic procedure, and Reiczigel et al. (2010) provided exact confidence intervals for the true prevalence assuming sensitivity and specificity were known. In this paper we propose a new method to construct approximate confidence intervals for the true prevalence when sensitivity and specificity are estimated from independent samples. To improve coverage we applied an adjustment similar to that described in Agresti and Coull (1998). According to an extensive simulation study the new confidence intervals maintain the nominal level fairly well even for sample sizes as small as 30; mini-mum coverage is above 88%, 93%, and 98% at nominal 90%, 95%, and 99%, respectively. We illustrate the advantages of the proposed method with real-life applications.

Mesh:

Year:  2014        PMID: 24416798     DOI: 10.1016/j.prevetmed.2013.09.015

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  18 in total

1.  Prevalence of bovine and avian tuberculosis in camel herds and associated public health risk factors in Isiolo County, Kenya.

Authors:  Peter O Lamuka; Francis M Njeruh; George C Gitao; Joseph Matofari; Richard Bowen; Khalif A Abey
Journal:  Trop Anim Health Prod       Date:  2018-03-26       Impact factor: 1.559

2.  Exact inference for the risk ratio with an imperfect diagnostic test.

Authors:  J Reiczigel; J Singer; Z S Lang
Journal:  Epidemiol Infect       Date:  2016-09-09       Impact factor: 4.434

3.  Epidemiology and impact of Fasciola hepatica exposure in high-yielding dairy herds.

Authors:  Alison Howell; Matthew Baylis; Rob Smith; Gina Pinchbeck; Diana Williams
Journal:  Prev Vet Med       Date:  2015-06-05       Impact factor: 2.670

4.  Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.

Authors:  Issaka Sagara; John Woodford; Mamady Kone; Mahamadoun Hamady Assadou; Abdoulaye Katile; Oumar Attaher; Amatigue Zeguime; M'Bouye Doucoure; Emily Higbee; Jacquelyn Lane; Justin Doritchamou; Irfan Zaidi; Dominic Esposito; Jennifer Kwan; Kaitlyn Sadtler; Alassane Dicko; Patrick Duffy
Journal:  medRxiv       Date:  2021-04-29

5.  SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.

Authors:  Matthew A Spinelli; Kara L Lynch; Cassandra Yun; David V Glidden; Michael J Peluso; Timothy J Henrich; Monica Gandhi; Lillian B Brown
Journal:  Lancet HIV       Date:  2021-04-29       Impact factor: 12.767

6.  Urban Planning and Health Inequities: Looking in a Small-Scale in a City of Cape Verde.

Authors:  Luzia Gonçalves; Zélia Santos; Miguel Amado; Daniela Alves; Rui Simões; António Pedro Delgado; Artur Correia; Jorge Cabral; Luís Velez Lapão; Isabel Craveiro
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

7.  Investigation of Anaplasma marginale Seroprevalence in a Traditionally Managed Large California Beef Herd.

Authors:  Thomas R Tucker; Sharif S Aly; John Maas; Josh S Davy; Janet E Foley
Journal:  Vet Med Int       Date:  2016-08-28

8.  Prevalence of Coxiella burnetii in German sheep flocks and evaluation of a novel approach to detect an infection via preputial swabs at herd-level.

Authors:  A Wolf; T L Prüfer; C Schoneberg; A Campe; M Runge; M Ganter; B U Bauer
Journal:  Epidemiol Infect       Date:  2020-03-16       Impact factor: 2.451

9.  Validation study of German inpatient administrative health data for epidemiological surveillance and measurement of quality of care for sepsis: the OPTIMISE study protocol.

Authors:  Daniel Schwarzkopf; Carolin Fleischmann-Struzek; Peter Schlattmann; Heike Dorow; Dominique Ouart; Andreas Edel; Falk A Gonnert; Jürgen Götz; Matthias Gründling; Markus Heim; Ulrich Jaschinski; Simone Lindau; Patrick Meybohm; Christian Putensen; Michael Sander; Konrad Reinhart
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692

10.  Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling.

Authors:  Carleen Klumpp-Thomas; Heather Kalish; Matthew Drew; Sally Hunsberger; Kelly Snead; Michael P Fay; Jennifer Mehalko; Anandakumar Shunmugavel; Vanessa Wall; Peter Frank; John-Paul Denson; Min Hong; Gulcin Gulten; Simon Messing; Jennifer Hicks; Sam Michael; William Gillette; Matthew D Hall; Matthew J Memoli; Dominic Esposito; Kaitlyn Sadtler
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.